Verrica Pharmaceuticals I... (VRCA)
NASDAQ: VRCA
· Real-Time Price · USD
5.15
-0.08 (-1.53%)
At close: Sep 04, 2025, 12:16 PM
-1.53% (1D)
| Bid | 5.1 |
| Market Cap | 48.61M |
| Revenue (ttm) | 14.7M |
| Net Income (ttm) | -48.6M |
| EPS (ttm) | -7.74 |
| PE Ratio (ttm) | -0.66 |
| Forward PE | -2.74 |
| Analyst | Hold |
| Ask | 5.32 |
| Volume | 10,656 |
| Avg. Volume (20D) | 54,825 |
| Open | 5.26 |
| Previous Close | 5.23 |
| Day's Range | 5.08 - 5.39 |
| 52-Week Range | 3.82 - 23.20 |
| Beta | 1.92 |
About VRCA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol VRCA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for VRCA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Verrica Pharmaceuticals Inc. is scheduled to release its earnings on
Nov 3, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
-4.99%
VRCA stock has given up its prior gain. Verrica Ph...
Unlock content with
Pro Subscription
1 month ago
-4.99%
Verrica Pharmaceuticals shares are trading higher after the company reported record growth for its YCANTH applicator.
